Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-05-21 @ 10:44 AM
Study NCT ID:
NCT01140360
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2010-06-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Sponsor:
Kent Robertson
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NF/Gleevec DOD Trial
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None